Altered glucose metabolism in Alzheimer's disease: role of mitochondrial dysfunction and oxidative stress

S Dewanjee, P Chakraborty, H Bhattacharya… - Free Radical Biology …, 2022 - Elsevier
Increasing evidence suggests that abnormal cerebral glucose metabolism is largely present
in Alzheimer's disease (AD). The brain utilizes glucose as its main energy source and a …

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and …

MU Rehman, N Sehar, NJ Dar, A Khan, A Arafah… - Neuroscience & …, 2023 - Elsevier
Neurodegenerative diseases (NDs) such as Alzheimer disease (AD), Parkinson disease
(PD), and Huntington disease (HD) represent a major socio-economic challenge in view of …

The biological pathways of Alzheimer disease: A review

M Calabrò, C Rinaldi, G Santoro… - AIMS …, 2020 - pmc.ncbi.nlm.nih.gov
Alzheimer disease is a progressive neurodegenerative disorder, mainly affecting older
people, which severely impairs patients' quality of life. In the recent years, the number of …

Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications

MS Uddin, LW Lim - Ageing research reviews, 2022 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder that usually develops slowly and
progressively worsens over time. Although there has been increasing research interest in …

Vitamin D in neurological diseases

D Plantone, G Primiano, C Manco, S Locci… - International journal of …, 2022 - mdpi.com
Vitamin D may have multiple effects on the nervous system and its deficiency can represent
a possible risk factor for the development of many neurological diseases. Recent studies are …

Cholinergic neuron targeting nanosystem delivering hybrid peptide for combinatorial mitochondrial therapy in Alzheimer's disease

K Qian, X Bao, Y Li, P Wang, Q Guo, P Yang, S Xu… - ACS …, 2022 - ACS Publications
Mitochondrial dysfunction in neurons has recently become a promising therapeutic target for
Alzheimer's disease (AD). Regulation of dysfunctional mitochondria through multiple …

Thioredoxin-interacting protein (TXNIP) with focus on brain and neurodegenerative diseases

H Tsubaki, I Tooyama, DG Walker - International journal of molecular …, 2020 - mdpi.com
The development of new therapeutic approaches to diseases relies on the identification of
key molecular targets involved in amplifying disease processes. One such molecule is …

Microglia and astrocytes in Alzheimer's disease: significance and summary of recent advances

Q Deng, C Wu, E Parker, TCY Liu, R Duan… - Aging and …, 2024 - pmc.ncbi.nlm.nih.gov
Alzheimer's disease, one of the most common forms of dementia, is characterized by a slow
progression of cognitive impairment and neuronal loss. Currently, approved treatments for …

The aging brain: Impact of heavy metal neurotoxicity

OM Ijomone, CW Ifenatuoha, OM Aluko… - Critical reviews in …, 2020 - Taylor & Francis
The aging process is accompanied by critical changes in cellular and molecular functions,
which upset the homeostatic balance in the central nervous system. Accumulation of metals …

Mitochondrial plasticity and synaptic plasticity crosstalk; in health and Alzheimer's disease

F Sayehmiri, F Motamedi, Z Batool… - CNS Neuroscience …, 2024 - Wiley Online Library
Synaptic plasticity is believed to underlie the cellular and molecular basis of memory
formation. Mitochondria are one of the main organelles involved in metabolism and energy …